Precigen, Inc.
PGENNASDAQHealthcare● Active
$3.57
$-0.01(-0.28%)
Market Cap$1.1B
P/E Ratio—
52W High$5.47
52W Low$1.3
Precigen, Inc. (PGEN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PGEN · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $9.68M | $3.92M | $6.22M | $26.91M | $14.27M |
| Cost of Revenue | $6.10M | $4.27M | $6.12M | $6.34M | $53.68M |
| Gross Profit | $3.59M | ($0.34M) | $0.11M | $20.57M | ($39.41M) |
| Gross Margin %(computed) | 37.05% | -8.71% | 1.70% | 76.44% | -276.24% |
| Operating Expenses | |||||
| R&D Expenses | $40.06M | $53.07M | $48.61M | $47.17M | $47.93M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $110.19M | $134.69M | $99.86M | $96.30M | $52.54M |
| Operating Income | ($106.60M) | ($135.03M) | ($99.76M) | ($75.73M) | ($91.95M) |
| Operating Margin %(computed) | — | — | — | -281.42% | -644.48% |
| Interest Income | $3.21M | $1.42M | $3.24M | $0.13M | $0.17M |
| Interest Expense | $3.87M | $0.01M | $0.47M | $6.77M | $18.75M |
| Income Before Tax | ($250.64M) | ($128.03M) | ($96.36M) | ($79.97M) | ($110.97M) |
| Income Tax Expense | $0.00M | ($1.79M) | ($0.46M) | ($0.19M) | ($0.16M) |
| Net Income | ($250.64M) | ($126.23M) | ($95.90M) | $28.32M | ($92.17M) |
| Net Margin %(computed) | — | — | — | 105.23% | -646.01% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.41 | $-0.47 | $-0.39 | $-0.33 | $-0.47 |
| Wtd Avg Shares | 304.71M | 267.73M | 244.54M | 200.36M | 197.76M |
| EBITDA | ($103.40M) | ($123.50M) | ($89.23M) | ($62.43M) | ($77.64M) |
| EBITDA Margin %(computed) | — | — | — | -231.99% | -544.22% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Precigen, Inc. data
About Precigen, Inc. (PGEN) Income Statement
Precigen, Inc. (PGEN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PGEN reported revenue of $0.01B, gross profit of $0.00B (gross margin 37.05%), and net income of ($0.25B) — a net profit margin of -2588.21%.
Frequently asked questions
PGEN · 4 questionsPrecigen, Inc. (PGEN) reported revenue of $0.01B for 2025, up 146.7% year-over-year.
PGEN revenuePGEN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08